Teleophthalmology in Preventive Medicine

  • Georg Michelson

Table of contents

  1. Front Matter
    Pages i-x
  2. Michael David Abràmoff, Meindert Niemeijer
    Pages 41-50
  3. Bernhard Höher, Georg Michelson, Peter Voigtmann, Bernhard Schmauss
    Pages 51-62
  4. Georg Michelson, Moritz Michelson
    Pages 81-92
  5. Thomas Köhler, Rüdiger Bock, Joachim Hornegger, Georg Michelson
    Pages 93-104
  6. Yuliya Naumchuk, Vinay A. Shah, Simon Kaja
    Pages 105-113

About this book

Introduction

This book provides an up-to-date overview of the clinical applications, methods, and technologies of teleophthalmology within the field of preventive medicine. The ability of novel methods to detect the initial signs of systemic and neurodegenerative diseases on the basis of alterations in the retina is reviewed, and detailed attention is paid to e role of teleophthalmology in screening for visionthreatening diseases such as diabetic retinopathy, and glaucoma. A major part of the book is devoted to novel imaging methods and the latest information technologies, including advanced mobile communication and Web 2.0 applications in teleophthalmology. In addition, the initial projects of an  interdisciplinary cooperation in preventive medicine are described. All of the authors are experienced in the scientific and practical aspects of teleophthalmology, including e-learning, and have produced a book that will meet the needs of all medical care providers interested in using teleophthalmology.

Keywords

Automated detection Early diagnosis Imaging devices Mass screening Systemic diseases

Editors and affiliations

  • Georg Michelson
    • 1
  1. 1.Department of OphthalmologyUniversity Erlangen-NürnbergErlangenGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-662-44975-2
  • Copyright Information Springer-Verlag Berlin Heidelberg 2015
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-662-44974-5
  • Online ISBN 978-3-662-44975-2
  • About this book
Industry Sectors
Biotechnology
Pharma